The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJudges Scientific Regulatory News (JDG)

Share Price Information for Judges Scientific (JDG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 11,500.00
Bid: 11,400.00
Ask: 11,600.00
Change: 100.00 (0.88%)
Spread: 200.00 (1.754%)
Open: 11,425.00
High: 11,500.00
Low: 11,450.00
Prev. Close: 11,400.00
JDG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half Year Trading Update and Notice of Results

25 Jul 2022 07:00

RNS Number : 5214T
Judges Scientific PLC
25 July 2022
 

Judges Scientific Plc

("Judges Scientific", "the Company" or "the Group")

Half Year Trading Update and Notice of Interim Results

Judges Scientific (AIM: JDG), the group focused on acquiring and developing companies in the scientific instrument sector, provides the following update regarding the Group's trading performance for the six-month period ended 30 June 2022.

The period has been one of continued resilience and progress as our Group recovers from the challenges of the pandemic, with much improved travel across most of the Group's markets, whilst still having to navigate worsening supply chain disruptions.

On 23 May 2022, the Group acquired Geotek Holding Limited and Geotek Coring Limited ('Geotek') for a consideration of up to £80m, funded by a new £100m multi-bank facility, which provides the Group with additional capacity to support the Group's buy and build strategy.

References to "Organic" information in this update exclude any contribution from Geotek.

Order intake 

Across the Group, Organic order intake was up 4.2% after a 25.1% gain in H1 2021; this shows 7.8% progress compared to H1 2019 although cannot be considered a full recovery to the pre-Covid growth trajectory. The Group saw growth in North America, up 15.4% (after 41% growth in H1 2021) and the Rest of the World, up 13.1% (after 8% improvement in H1 2021). The Rest of Europe was flat (after 34% growth in H1 last year) reflecting varied performances across the region. China/Hong Kong, which continued to be affected by strict lockdowns over the period, receded 5.1% (after 2% growth in H1 2021). The UK, which had progressed 26% in H1 2021, was down 9.4%. Order intake still varied considerably from business to business, although less so than in H1 2021.

Order book

The Organic order book reached a mid-year record of 21.3 weeks (17.6 weeks at 30 June 2021 and 23 weeks at 1 January 2022), aided by the modest increase in order intake and by the ongoing supply chain difficulties.

Revenue

Organic sales in the first half were up 7% compared with H1 2021. Further progress was hindered by supply chain issues, by staff shortages caused both by recruitment difficulties and by numerous colleagues having to isolate.

First Half Performance and Outlook

The board expects the growth in Organic revenues to have driven improved profitability in H1. Whilst general market conditions remain challenging, our resilient business model, backed up by a strong order book, gives the board confidence that the current market expectations for the full year (revised to include Geotek) will be met. 

 

Notice of Results

The Company intends to announce its interim results for the six months to 30 June 2022 on Thursday 22 September 2022.

 

For further information please contact:

Judges Scientific

David Cicurel, CEO

Brad Ormsby, Group FD

Tel: +44 (0) 20 3829 6970

 

Shore Capital (Nominated Adviser & Broker)

Stephane Auton

Iain Sexton

Tel: +44 (0) 20 7408 4090

 

Liberum (Joint Broker)

Edward Mansfield

William Hall

 

Media enquiries:

Alma PR (Financial Public Relations)

 

Tel: +44 (0) 20 3100 2222

 

Sam Modlin

Justine James

Joe Pederzolli

 

Tel: +44 (0) 20 3405 0205

judges@almapr.co.uk

Notes to editors:

Judges Scientific plc (AIM: JDG), is a group focused on acquiring and developing companies in the scientific instrument sector. The Group now consists of 20 businesses acquired since 2005.

The acquired companies are primarily UK-based with products sold worldwide to a diverse range of markets including: higher education institutions, scientific research facilities, manufacturers and regulatory authorities. The UK is a recognised centre of excellence for scientific instruments. The Group has received five Queen's Awards for innovation and export. 

The Group's companies predominantly operate in global niche markets, with long term growth fundamentals and resilient margins.

Judges Scientific maintains a policy of selectively acquiring businesses that generate sustainable profits and cash. Shareholder returns are created through the reduction of debt, organic growth and dividends. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTGZGZNZZFGZZZ
Date   Source Headline
9th May 20247:00 amRNSPurchase of Ordinary Shares
8th May 20241:21 pmRNSDirector/PDMR Shareholding
3rd May 20243:01 pmRNSNotice of General Meeting
1st May 20247:00 amRNSTotal Voting Rights
16th Apr 20247:00 amRNSDirector/PDMR Shareholding
9th Apr 20245:29 pmRNSDirector/PDMR Shareholding
2nd Apr 202410:41 amRNSTotal Voting Rights - Correction
2nd Apr 20249:03 amRNSTotal Voting Rights
25th Mar 20246:01 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSFinal Results
7th Mar 20247:00 amRNSDirector/PDMR Shareholding
4th Mar 202411:04 amRNSTotal Voting Rights
22nd Feb 20245:20 pmRNSHolding(s) in Company
6th Feb 20243:03 pmRNSDirector/PDMR Shareholding
5th Feb 20249:32 amRNSTotal Voting Rights
1st Feb 20247:00 amRNSAcquisition of Luciol Instruments SA
24th Jan 20245:52 pmRNSGrant of Options
18th Jan 20247:00 amRNSFull Year Trading Statement and Notice of Results
8th Jan 20242:21 pmRNSDirector/PDMR Shareholding
2nd Jan 202410:49 amRNSTotal Voting Rights
21st Dec 20234:16 pmRNSDirector/PDMR Shareholding
21st Dec 20239:13 amRNSBlock listing Interim Review
7th Dec 202311:18 amRNSDirector/PDMR Shareholding
1st Dec 202311:20 amRNSTotal Voting Rights
22nd Nov 202310:41 amRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSBoard Changes
15th Nov 202312:54 pmRNSDirector/PDMR Shareholding
9th Nov 202312:36 pmRNSDirector/PDMR Shareholding
9th Oct 202311:36 amRNSDirector/PDMR Shareholding
3rd Oct 202311:13 amRNSTotal Voting Rights
26th Sep 202310:37 amRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSNotice of Investor Presentation
2nd Aug 20233:02 pmRNSTotal Voting Rights
26th Jul 202311:20 amRNSDirector/PDMR Shareholding
18th Jul 20237:00 amRNSHalf Year Trading Update and Notice of Results
10th Jul 20233:03 pmRNSDirector/PDMR Shareholding
3rd Jul 20233:44 pmRNSTotal Voting Rights
22nd Jun 20233:09 pmRNSBlock listing Interim Review
14th Jun 20238:44 amRNSDirector/PDMR Shareholding
6th Jun 20238:45 amRNSPayment of Earn-out and Issue of Equity
5th Jun 20234:17 pmRNSDirector/PDMR Shareholding
1st Jun 20237:00 amRNSBlocklisting Application and Total Voting Rights
22nd May 20231:45 pmRNSResult of AGM
12th May 20232:01 pmRNSPurchase of Ordinary Shares
9th May 202312:37 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSNotice of AGM
2nd May 20231:00 pmRNSTotal Voting Rights
2nd May 20237:00 amRNSAcquisition of Bossa Nova Vision LLC
25th Apr 20235:55 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.